BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6090244)

  • 1. Butyrate inhibits the retinoic acid-induced differentiation of F9 teratocarcinoma stem cells.
    Levine RA; Campisi J; Wang SY; Gudas LJ
    Dev Biol; 1984 Oct; 105(2):443-50. PubMed ID: 6090244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective post-translational modification of collagen IV in a mutant F9 teratocarcinoma cell line is associated with delayed differentiation and growth arrest in response to retinoic acid.
    Wang SY; Roguska MA; Gudas LJ
    J Biol Chem; 1989 Sep; 264(26):15556-64. PubMed ID: 2549067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dibutyryl cyclic AMP and butyrate on F9 teratocarcinoma cellular retinoic acid-binding protein activity.
    Grippo JF; Gudas LJ
    J Biol Chem; 1987 Apr; 262(10):4492-500. PubMed ID: 3031026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells.
    Stoner CM; Gudas LJ
    Cancer Res; 1989 Mar; 49(6):1497-504. PubMed ID: 2538228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP.
    Strickland S; Smith KK; Marotti KR
    Cell; 1980 Sep; 21(2):347-55. PubMed ID: 6250719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of gene sequences transcriptionally regulated by retinoic acid and dibutyryl cyclic AMP in cultured mouse teratocarcinoma cells.
    Wang SY; LaRosa GJ; Gudas LJ
    Dev Biol; 1985 Jan; 107(1):75-86. PubMed ID: 2981185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of PLC-gamma during the differentiation of mouse F9 teratocarcinoma cells.
    Lee YH; Lee HY; Ryu SH; Suh PG; Kim KW
    Cancer Lett; 1993 Feb; 68(2-3):237-42. PubMed ID: 8383002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and characterization of F9 teratocarcinoma stem cell mutants with altered responses to retinoic acid.
    Wang SY; Gudas LJ
    J Biol Chem; 1984 May; 259(9):5899-906. PubMed ID: 6325455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclic adenosine monophosphate-mediated induction of F9 teratocarcinoma differentiation in the absence of retinoic acid.
    Goldstein B; Rogelj S; Siegel S; Farmer SR; Niles RM
    J Cell Physiol; 1990 May; 143(2):205-12. PubMed ID: 1692026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditions affecting the differentiation of F9 teratocarcinoma cells: potentiation of response by cyclic AMP.
    Grover A; Adamson ED
    In Vitro Cell Dev Biol; 1986 May; 22(5):280-4. PubMed ID: 2423499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The induction of differentiation in teratocarcinoma stem cells by retinoic acid.
    Strickland S; Mahdavi V
    Cell; 1978 Oct; 15(2):393-403. PubMed ID: 214238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of cDNA clones specific for collagen IV and laminin from mouse teratocarcinoma cells.
    Wang SY; Gudas LJ
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5880-4. PubMed ID: 6310600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible effects of dibutyryl cAMP on laminin and type IV collagen secretion from retinoic acid treated F9 cells.
    Morita A; Kitagawa Y; Sugimoto E
    J Cell Physiol; 1985 Nov; 125(2):263-72. PubMed ID: 2997239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum.
    Nagarajan L; Jetten AM; Anderson WB
    Exp Cell Res; 1983 Sep; 147(2):315-27. PubMed ID: 6193979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid modulation of transmembrane signaling. Analysis in F9 teratocarcinoma cells.
    Galvin-Parton PA; Watkins DC; Malbon CC
    J Biol Chem; 1990 Oct; 265(29):17771-9. PubMed ID: 2170395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An increase in prolyl-4-hydroxylase activity occurs during the retinoic acid-induced differentiation of mouse teratocarcinoma stem cell lines F9 and P19.
    Roguska MA; Gudas LJ
    J Biol Chem; 1985 Nov; 260(26):13893-6. PubMed ID: 2997185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth medium and cyclic AMP analogues on the cAMP-induced differentiation of F9 teratocarcinoma cells.
    Goldstein B; Kindregan H; Niles RM
    In Vitro Cell Dev Biol; 1991 Feb; 27A(2):158-62. PubMed ID: 1708373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranscriptional regulation of the expression of CAD gene during differentiation of F9 teratocarcinoma cells by induction with retinoic acid and dibutyryl cyclic AMP.
    Rao GN; Church RL; Davidson JN
    FEBS Lett; 1988 May; 232(1):238-42. PubMed ID: 2896607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein synthesis inhibitors prevent the induction of laminin B1, collagen IV (alpha 1), and other differentiation-specific mRNAs by retinoic acid in F9 teratocarcinoma cells.
    Wang SY; Gudas LJ
    J Cell Physiol; 1988 Aug; 136(2):305-11. PubMed ID: 2842348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratocarcinoma F9 cells induced to differentiate with sodium butyrate produce both tissue-type and urokinase-type plasminogen activators.
    Takeda M; Kosaka M; Nishina Y; Sawada K; Matsumoto K; Nishimune Y
    J Cell Biochem; 1992 Jul; 49(3):284-9. PubMed ID: 1644865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.